Christine Bellon serves as Executive at Beam Therapeutics Inc., where they oversee executive responsibilities. Since joining the company, Christine Bellon has executed 14 insider transactions totaling $544.6K, demonstrating a bearish approach to their equity position. Their most recent transaction on Oct 1, 2025 involved selling 373 shares valued at $9.1K.
Christine Bellon currently holds 116,921 shares of Beam Therapeutics Inc. (BEAM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christine Bellon has been a net seller of BEAM stock. They have purchased $0 and sold $544.6K worth of shares.
Christine Bellon's most recent insider trade was on Oct 1, 2025, when they sold 373 shares at $24.53 per share.
Get notified when new Form 4 filings are submitted
| $32.12 |
| Planned |
| Mar 31, 2024 | BEAM | $0 | Award | 27,500 | $N/A | Discretionary |
| Jan 3, 2024 | BEAM | $50.4K | Sale | 1,907 | $26.42 | Planned |
| Nov 20, 2023 | BEAM | $30.2K | Option Exercise | 4,182 | $7.22 | Planned |
| Nov 20, 2023 | BEAM | $42.0K | Option Exercise | 5,818 | $7.22 | Planned |
| Nov 20, 2023 | BEAM | $150.0K | Sale | 5,000 | $30.00 | Planned |
| Nov 20, 2023 | BEAM | $155.0K | Sale | 5,000 | $31.00 | Planned |
| Oct 2, 2023 | BEAM | $8.9K | Sale | 388 | $22.85 | Planned |
| Apr 4, 2023 | BEAM | $33.8K | Sale | 1,161 | $29.09 | Planned |
| Apr 3, 2023 | BEAM | $28.2K | Sale | 931 | $30.31 | Planned |
| Mar 31, 2023 | BEAM | $0 | Award | 17,500 | $N/A | Discretionary |
| Mar 30, 2023 | BEAM | $19.3K | Option Exercise | 2,669 | $7.22 | Discretionary |
| Mar 30, 2023 | BEAM | $45.3K | Option Exercise | 6,272 | $7.22 | Discretionary |